Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

NCT00530075 is registered in ClinicalTrials.gov with Nippon Kayaku Co., Ltd. as lead sponsor.

NCT NCT00530075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Lead sponsor
Nippon Kayaku Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
February 28, 2006
Enrollment
45 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

wegener's granulomatosis